New French Pharma Industry Head Faces Tough Challenges On Drug Spending
Executive Summary
Leem’s new president says one of his priorities is to discuss the implementation of measures agreed earlier this year to speed up access to innovative medicines. But he also faces a number of other challenges, including the squeeze on pharmaceutical spending.
You may also be interested in...
French Industry Welcomes Moves To Speed Up Access To Innovative Drugs
A French government/industry discussion forum has come up with concrete plans for accelerating access to innovative medicines by streamlining clinical trial approval and price negotiations.
French Govt Must Act To Stop ‘Inexorable Decline’ Of Pharmaceutical Industry
The president of France’s industry association Leem says the authorities need to look at new ways of handling the health technology evaluation and pricing of innovative drugs, and to implement more predictable, long-term health policies, if the country is to reverse the “inexorable decline” of the pharmaceutical sector.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.